Skip to main content
Category

In the News

VIDEO: “Can poor sleep cause Alzheimer’s?” with Dr. Bryce Mander

By Commentary, Community Events, In the News
Facebook Live Series - ASK THE DOC: Alzheimer's Research Today! This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) the first Friday of every month from 9:00-9:30 AM PST to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. Episode 1: "Can poor sleep cause Alzheimer's?" Bryce Mander, PhD, is Assistant Professor of Psychiatry & Human Behavior at UCI. He received his…
Read More

Leslie Thompson gets $6 million CIRM grant to advance Huntington’s disease treatments

By In the News
  Leslie Thompson, PhD, Chancellor's Professor of Psychiatry & Human Behavior, Neurobiology & Behavior (Photo credit: Steve Zylius/UCI) UCI News, January 30, 2019 - "Leslie Thompson of the Sue & Bill Gross Stem Cell Research Center and UCI MIND has been awarded $6 million by the California Institute for Regenerative Medicine to continue her CIRM-supported efforts to create stem cell treatments for Huntington’s disease. The funding will allow the Thompson lab to conduct the late-stage testing needed to apply to the U.S. Food and Drug Administration for permission to start a clinical trial in people. The therapy involves transplanting stem cells…
Read More

New play aims to educate community on Down syndrome

By Community Events, In the News
Eric Doran, Manager of UCI MIND’s Down Syndrome Program, has partnered with his longtime friend and playwright, Steven Oberman, to tell the true story of Dr. John Langdon Down, the man who first described Down syndrome. We interviewed Mr. Doran to learn more about the vision behind this new play, Blurred at the Edges, set to run in March of 2019 at the Diversionary Theatre in San Diego. Eric Doran, MS What is the vision behind Blurred at the Edges? Down syndrome is named after Dr. John Langdon Down, a British physician who first described the condition in 1866. Most…
Read More

The Rise of Pseudomedicine for Dementia and Brain Health

By Commentary, In the News
Contributed by Joshua Grill, PhD, Director of UCI MIND Colleagues at the UCSF Memory and Aging Center published a timely critique in JAMA on a concerning and increasing practice in the United States. “Pseudomedicine” is a practice whereby qualified healthcare professionals prescribe supplements or other therapies that are not covered by insurance, and therefore require cash payments, for personal financial gain. Pseudomedicine is especially problematic among older patients and family members concerned about memory loss and desperate for effective therapies to slow or stop the progression of Alzheimer’s disease. Other examples of pseudomedicine include recommendations for brain healthy diet plans…
Read More

NPR asks founding director to comment on exercise study

By Carousel Slider, In the News
Carl Cotman, PhD A study was recently published in the journal Neurology about physical activity's relation to Alzheimer's disease and cognition in older adults. NPR asked UCI MIND founding director Dr. Carl Cotman to comment on this impressive study, noting that exercise might "'offset the ill effects of brain degeneration.' He adds that lifestyle interventions such as an increase in physical activity and movement can be powerful even in the presence of disease." Click here to read the article > Dr. Cotman is leading a national clinical trial of exercise at UCI MIND. The trial aims to evaluate whether 18 months…
Read More

Sleep is associated with tau pathology in early Alzheimer’s disease

By Community Events, In the News
Bryce Mander, PhD Colleagues at Washington University School of Medicine published novel findings on the correlation between tau tangles, a hallmark of Alzheimer’s disease pathology, and sleep quality in people who were cognitively normal or who had mild cognitive impairment. On ALZFORUM, UCI MIND faculty member, Dr. Bryce Mander commented, “This is an important paper because it shows for the first time how tau is related to sleep deficits. That’s going to be important in advancing our understanding of how Alzheimer’s disease pathology affects sleep.” Dr. Mander, Assistant Professor of Psychiatry & Human Behavior at UCI, has published several important findings on…
Read More

Dr. Ira Lott, Director of UCI MIND Down Syndrome Program, featured in OC Business Journal

By Carousel Slider, In the News
Dr. Ira Lott, Director of the UCI MIND Down Syndrome Program, discussed the connection between Down syndrome and Alzheimer’s disease with the Orange County Business Journal this week.  Dr. Lott and his team conduct critical research studies with volunteer participants to improve understanding of brain aging and dementia in Down syndrome. Click here to read the article > To learn more about studies in Down syndrome and Alzheimer’s disease, click here >
Read More

Critical need for diversity in Alzheimer’s disease research

By Commentary, In the News
Contributed by Joshua Grill, PhD, Director of UCI MIND In a new study, colleagues at the Alzheimer's Disease Research Center at Washington University have found that levels of the cerebrospinal fluid protein tau, one of the hallmark pathologies in Alzheimer’s disease (AD), is lower in African Americans compared to Whites. This was true both for older participants who did and did not have memory problems. The study is not the first to find such differences between African Americans and Caucasians and it has important implications to a number of important areas of AD research. First, there is a growing movement…
Read More

Novel genetics research opens door to potential new therapies for dementia

By Carousel Slider, In the News
Vivek Swarup, PhD, Assistant Professor of Neurobiology & Behavior UCI MIND faculty member, Dr. Vivek Swarup, and colleagues at UCLA, Takeda Pharmaceutical Co. Ltd. in Japan, Emory University School of Medicine, Harvard Medical School, and the Perelman School of Medicine at the University of Pennsylvania, published novel findings yesterday in Nature Medicine on two major groups of genes associated  with Alzheimer’s disease and frontotemporal dementia and unraveled a novel microRNA, miR-203, as a master regulator of neuronal death. In human cell cultures containing AD-associated mutations, the researchers showed that certain experimental drugs altered the loss of brain cells associated with neurodegenerative disease. Dr. Swarup says, “I’m hopeful these important findings…
Read More

Fall 2018 Newsletter – In this issue of MIND Matters

By In the News
Fall 2018 Newsletter - In this issue of MIND Matters: - Grand Opening of UCI Sleep Center led by Dr. Ruth Benca - Wine for the MIND hosted by Bob & Virginia Naeve - Meet the REMIND Co-Chairs - Study Partners in Alzheimer's Research: Gwen Ritchie - Philanthropist Highlight: Greg & Cindy Lai - Donations, Sept 2017-2018 ----- Click to read the Fall 2018 Newsletter - MIND Matters
Read More

Dr. Blurton-Jones awarded grant to identify potential treatments for Alzheimer’s disease

By Carousel Slider, In the News
UCI MIND faculty member Dr. Mathew Blurton-Jones was awarded a $500,000 grant from Orange County Community Foundation to test 1200+ FDA-approved compounds for effectiveness in Alzheimer's disease treatment. His lab seeks to find the top 20 genes and drugs that safely prevent brain damage caused by microglia, which are critical immune cells in the brain that 'prune' unnecessary neuronal connections, or synapses. In the brains of people with Alzheimer's disease, damage can be caused by microglia 'overpruning' synapses, leading to loss of necessary connections. UCI News reports that Dr. Blurton-Jones and his team are "grateful to be the recipients of this…
Read More

UCI MIND selected as Center of Excellence to conduct clinical trials in Down Syndrome and Alzheimer’s disease

By Carousel Slider, In the News
Dr. Ira Lott with research participant in UCI MIND Down Syndrome Program UCI MIND faculty member, Dr. Ira Lott, is one of the world's leading experts in unraveling the link between Down syndrome and Alzheimer's disease (Learn more in the Winter 2016 issue of MIND Matters). His team has been selected as a Center of Excellence for the new Down Syndrome Clinical Trial Network (DS-CTN) launched by LuMIND, a Down syndrome research foundation. As part of this important network, Dr. Lott and his team will receive funding to conduct clinical trials of promising therapies for participants with Down syndrome, at…
Read More

Sandra Day O’Connor announces dementia diagnosis

By In the News
Karen Bleier/AFP/Getty Images In a letter released on Tuesday, October 23, retired supreme court justice Sandra Day O'Connor announced a diagnosis of probable Alzheimer's dementia, and that she will begin stepping down from public life. O'Connor, the first woman to serve on the Supreme Court, was a devoted caregiver to her husband John after his Alzheimer's diagnosis in 2005. NPR reports the reaction of Chief Justice John Roberts: "I was saddened to learn that Justice Sandra Day O'Connor, like many Americans, faces the challenge of dementia. But I was not at all surprised that she used the occasion of sharing that…
Read More

Dr. Joshua Grill discusses A4 Study results in Alzforum

By Carousel Slider, Commentary, In the News
This week Alzforum posted coverage from the Alzheimer’s Association International Conference, including UCI MIND Director Dr. Joshua Grill's presentation of data from The A4 Study (Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease Study). In The A4 Study, a secondary prevention trial of late-onset Alzheimer's disease, people with elevated amyloid had higher levels of memory complaints than those without elevated amyloid. To read the full article, click here > 
Read More

Orange Coast Magazine calls upcoming conference a “Can’t-Miss” health event in OC

By Carousel Slider, Community Events, In the News
Orange Coast Magazine​ just named our upcoming research conference in the "20 Can’t-Miss Health Events in O.C. To Keep You Healthy!" Don't miss your chance to attend Trials Today, Treatments Tomorrow, Sept. 21 at the Irvine Marriott​. Tickets: http://bit.ly/alzconference or call 949.757.3720 x 3733. "Alzheimer’s affects more than 84,000 people in Orange County. This conference, hosted by the UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND) and Alzheimer’s Orange County, will bring world-renowned experts to Irvine to discuss progress in the battle against Alzheimer’s." -- Orange Coast Magazine  
Read More

UCI MIND needs volunteers for clinical trials on Alzheimer’s disease

By Carousel Slider, In the News
UCI MIND Director Dr. Joshua Grill wrote an article for the Daily Pilot about the need for Alzheimer's clinical trial research participants in Orange County. Read an excerpt below, and click here for the full article > "Here in Orange County, we are home to the Alzheimer’s Disease Research Center, the UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND). And we are making progress. There will be one essential key to needed advances, however. You. We need more people to participate in research, especially clinical trials of promising treatments. Clinical trial participants in Alzheimer’s research, much like…
Read More

New York Times article breaks down barriers to recruitment and brings hope with a new trial

By Commentary, In the News
Photo credit: Zack Wittman for The New York Times The New York Times recently covered a new clinical trial effort Eli Lilly is undertaking, the TRAILBLAZER-ALZ clinical research study. The study, which UCI MIND investigators are participating in, aims to enroll 375 people with early Alzheimer's disease. To learn more about the TRAILBLAZER-ALZ study, click here, or contact us at research@mind.uci.edu or call 949.824.0008.
Read More

UCI Researchers awarded grant to explore gender differences in Alzheimer’s

By Commentary, In the News
Sunil Gandhi (left) and Mathew Blurton-Jones (right)Steve Zylius / UCI Currently, 2 out of every 3 people with Alzheimer's disease are women. Last year, UCI MIND began a partnership with Maria Shriver's Women's Alzheimer's Movement. This partnership launched a grant competition focused on understanding the role of sex in Alzheimer's disease. UCI researchers Sunil Gandhi and Mathew Blurton-Jones have been awarded this year's $100,000 grant. Their research will focus on the role of microglia in the brains of men and women using induced pluripotent stem cells generated from skin cells donated by UCI ADRC participants, modern mouse models of the…
Read More

We’re happy to hear good news, but we still need to see the data

By Commentary, In the News
This week, BioArctic Neuroscience, Esai, and Biogen made headlines when they announced via press release the topline and positive results of their Phase 2a study of the anti-amyloid antibody BAN2401. The press release indicated that the drug “demonstrated statistically significant slowing in clinical decline and reduction of amyloid beta accumulated in the brain” in patients with early Alzheimer’s disease. To be sure, this is welcomed news. Too often headlines for Alzheimer’s disease clinical trials are about “flops” and “failures.” So we should take this good news and embrace it. Unfortunately, there remain many questions to which we need answers before we…
Read More

Remembering the contributions of Nobel laureate Dr. Arvid Carlsson in the field of Parkinson’s disease

By In the News
Dr. Arvid Carlsson passed away this past Friday at the age of 95. His research into dopamine led to the development of treatments for Parkinson's disease, a neurodegenerative disease that involves tremors and rigidity. Dr. Carlsson showed that dopamine was a neurotransmitter and that it is critical to movement. Dopamine is depleted in Parkinson’s disease and the drug L-dopa can be used to treat patients with this neurological disease. Dr. Carlsson's findings earned him the 2000 Nobel Prize in Physiology or Medicine, along with noted American researchers Dr. Eric Kandel and Paul Greengard. UCI MIND is grateful for the work…
Read More

Possible link between human herpes viruses and Alzheimer’s disease

By Commentary, In the News
Recent scientific reports, one in the journal Neuron and another coming out in the journal Cell, present some intriguing new data indicating a link between human herpes viruses and Alzheimer’s disease (AD). Because the majority of AD cases cannot be attributed to genetics alone, there has been keen interest in finding other factors that affect the risk of developing AD. Head trauma and infections are two such factors that have received attention by researchers. With regard to infectious agents, speculation has often centered on the herpes viruses, especially herpes simplex virus 1 (HSV1). Human herpes viruses are neurotropic, which means they…
Read More

Dean Frank LaFerla Reappointed to Second 5-Year Term

By In the News
UCI MIND sends a hearty congratulations to Dr. Frank LaFerla, who has been appointed to a second five-year term as dean of the UCI School of Biological Sciences. As Dean, Dr. LaFerla has taken the school to new heights, launching successful public lecture series, increasing philanthropy, and of course supporting cutting edge research. During his tenure, research funding in the school has grown by 35 percent and 15 new outstanding faculty members have been hired. Please join us in congratulating Dean LaFerla on this reappointment. Learn more >
Read More

Congratulations to Burton Young and the 2018 Orange County Men of Character Honorees

By In the News
Danny Harper & Burton Young By Danny Harper, Senior Director of Development The faculty and staff of UCI MIND, congratulate Burton Young and his fellow honorees on receiving the Men of Character recognition by the Orange County Boy Scouts of America. I had the pleasure of attending this year’s event, and I was inspired by the stories of the six men who were honored. While each shared his unique journey, there were consistent themes in each of their stories. Each, in his turn, spoke about the importance of hard work, giving back and family. These themes resonate deeply with my…
Read More

Dr. Joshua Grill on Mild Cognitive Impairment

By Carousel Slider, In the News
UCI MIND Director, Dr. Joshua Grill, recently discussed Mild Cognitive Impairment (MCI) with Being Patient, a news site building single-subject platforms around complex health topics. Click here to read the article and learn: Is MCI reversible? Is MCI a precursor to Alzheimer's? How soon will MCI progress to Alzheimer's? What are the warning signs of MCI? Will I recognize my own MCI? What can I do to delay MCI? UCI MIND has a number of research studies currently enrolling people with MCI or memory concerns.  To learn about studies for which you may be eligible, enroll in the UCI C2C Registry…
Read More

Remembering Carl Kasell

By In the News
(Chip Somodevilla/Getty Images) By Danny Harper, Senior Director of Development, UCI MIND Every year, hundreds of thousands of Americans lose friends and loved ones to Alzheimer’s disease. When a celebrity passes from Alzheimer’s, it brings a higher level of attention to the disease that affects millions of Americans and more than 84,000 people right here in Orange County. Whether or not you personally know someone who has lived with Alzheimer’s, we can all get a glimpse into the disease through the lives of public figures who have been afflicted. From Rosa Parks to Ronald Reagan to Glen Campbell, and now including NPR’s…
Read More

Brain health is on the minds of seniors who attended UCI MIND “Ask the Doc” open Q&A session at Susi Q

By Community Events, In the News
Joshua Grill, Malcolm Dick, Ann Quilter, Lindsay Hohsfield, and Aimee Pierce Story by Dianne Russell in Stu News Laguna featuring UCI MIND's most recent Ask the Doc panel on March 22, 2018: "Although the day is wet and dreary, it doesn’t stop 85 audience members from attending UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND) “Ask the Doc” event at Susi Q. The roomful of mostly seniors is serious and here for one thing, to get answers to their questions regarding the widespread problem of Alzheimer’s, memory loss and brain health. It’s not an entirely comfortable situation, as…
Read More

Alzheimer’s research funding gets a $414 million boost

By In the News
Getty Images This week, Congress finalized the 2018 budget for the National Institutes of Health (NIH), which included a $414 million increase in funding for Alzheimer's disease research. This brings the total amount of dementia research funding to $1.8 billion. Thank you to all, including our research participants, faculty, staff, and community partners, who advocate tirelessly for increased funding, resources, and awareness for Alzheimer's disease. "Costs for treating Alzheimer’s in particular eat up billions in federal spending each year, something lawmakers said could be prevented if the NIH can develop a cure," The Hill reported (read more>). Continued investment in…
Read More

The role of exercise in reducing or slowing Alzheimer’s disease

By Commentary, In the News
Contributed by Carl Cotman, PhD, Founding Director of UCI MIND The role of exercise in reducing or slowing Alzheimer’s disease keeps coming up on headlines. Observational studies like the one in this article suggest that brain health may be different for older adults who exercise versus those who do not. While the results of studies like this one are intriguing, disease modifying effects need to be demonstrated in a larger and more diverse populations using accessible, cost-effective and sustainable programs that have the potential for implementation in a community setting. To address this need, UCI MIND and the Alzheimer's Disease Cooperative…
Read More

Sleepy older adults accumulate amyloid pathology more quickly

By Commentary, In the News
Contributed by Bryce Mander, PhD As reported in CNN, a new study published in JAMA Neurology indicates that healthy older adults who are excessively sleepy during the day show a greater buildup over time of β-amyloid plaques, a defining brain feature of Alzheimer’s disease, compared to those who are not excessively sleepy. As we describe in our editorial on this article, this study is an important advance in our understanding of how sleep disturbance in general can result in increased risk for Alzheimer’s disease. Many studies over the past few years, including our own, have linked poor sleep to increased…
Read More

UCI researchers find a way to help older brains form memories

By In the News
Marcelo Wood, PhD Dr. Marcelo Wood, UCI MIND faculty member and chair of neurobiology and behavior, and his team have discovered a way to help old and damaged brains form long-term memories by unlocking a repressed gene. Wood presented the findings at the American Association for the Advancement of Science conference earlier this month.  Next, Wood's team plans to investigate how these findings apply to people with Alzheimer's disease to formulate ideas for drug development. READ MORE FROM THE DAILY PILOT >
Read More

The 90+ Study finds link between moderate Alcohol Consumption and Longevity

By In the News
UCI MIND faculty investigator, Dr. Claudia Kawas, presented findings from The 90+ Study at the American Association for the Advancement of Science’s annual conference this past weekend, highlighting the link between moderate alcohol consumption and longevity. In an observational study of participants age 90 and older, Dr. Kawas and her team found that consuming about two glasses of beer or wine daily was associated with 18% reduced risk of premature death. Findings also suggest regular exercise, social and cognitive engagement, and a few extra pounds in older age are associated with longevity. To learn more about The 90+ Study, click HERE or contact 949.768.3635 or study90@uci.edu.…
Read More

Bill Gates reveals personal reason he’s helping fight Alzheimer’s disease

By In the News
Bill Gates with father, Bill Gates Sr. Charitable billionaire Bill Gates recently announced a $100 million pledge to fight Alzheimer's disease, but today he reveals why the disease hits close to home. His father, 92 year-old Bill Gates Sr., is one of the 5.5 million people in the United States with Alzheimer's disease. Click here to read the article and watch his interview with Maria Shriver at TODAY.com >
Read More

The Crowd: Maria Shriver honored at UCI MIND’s gala

By In the News
Honoree Maria Shriver with donor and Alzheimer’s research participant Ann Quilter of Laguna Beach, center, and Aimee Pierce, MD, medical director of the UCI MIND Memory Assessment Research Center. (Photo by Stan Sholik) By B.W. Cook January 16, 2018 Daily Pilot Opinion "At appropriate times past, I have broken my strict rule not to interject my personal life stories into this column. With that said, anything to do with the pursuit of an Alzheimer's disease cure and/or care compels me to share private family experience. Alzheimer's devastated my talented, intelligent mother at the early age of 65 and it ripped…
Read More

Why Are Women at Higher Risk of Alzheimer’s?

By In the News
New research partnership aims to better understand the Alzheimer's gender divide By Madeline Vann, Caring.com Health Writer "One of the biggest risk factors for Alzheimer’s disease you may not have heard of? Being a woman. More women than men live with Alzheimer’s, a type of dementia that causes problems with memory, behavior and thinking. According to the Alzheimer’s Association, women make up two thirds of the roughly 5.5 million Americans living with the disease, but experts do not yet understand why. Now, the University of California at Irvine’s Institute for Memory Impairments and Neurological Disorders (UCI MIND) and Maria Shriver’s…
Read More

Maria Shriver’s Women’s Alzheimer’s Movement Partners with UCI MIND to Launch New Women-Focused Research Initiative

By In the News
UCI MIND Co-Directors, Drs. Joshua Grill and Frank LaFerla with Maria Shriver at the annual UCI MIND gala on December 2, 2017 at the Balboa Bay Resort More than 5.5 million Americans have Alzheimer’s disease. Two-thirds of them are women. The initiative will fund critical new women-based research. ORANGE COUNTY, Calif., (December 5, 2017) — A new partnership in Orange County, California is seeking answers to an essential question affecting global health: Why do more women get Alzheimer’s disease than men? UCI MIND, the University of California at Irvine’s Institute for Memory Impairments and Neurological Disorders, has announced a new research initiative…
Read More

New study estimates 47 million Americans with preclinical Alzheimer’s disease

By In the News
In a study published today in Alzheimer’s & Dementia, UCI MIND faculty members Drs. Claudia Kawas and Maria Corrada, and colleagues at UCLA, reported the first estimates of preclinical Alzheimer’s disease (AD) and mild cognitive impairment (MCI) prevalence in the United States. According to the study, 2.4 million Americans are living with MCI due to AD (memory and other cognitive problems that do not meet criteria for dementia), and this number is expected to more than double by 2060. Moreover, the researchers estimated about 47 million Americans have preclinical AD, the presence of amyloid accumulation and/or neurodegeneration with no symptoms of memory…
Read More

A December to Remember ticket sales end Thursday at noon!

By Community Events, In the News
Don’t miss an unforgettable evening of fun and philanthropy in support of Alzheimer’s disease research this Saturday, December 2nd at the Balboa Bay Resort in Newport Beach! If you haven’t done so already, purchase your ticket or table today to join esteemed researchers from UCI MIND, gala honorees Maria Shriver and Suzy Melin, and philanthropists for one night that will have a lasting impact in the fight against Alzheimer’s disease. A December to Remember Sponsors The Beaumont Family, in Honor of Dr. Jacqueline DuPont The Covington Elite OC Productions HCP, Inc. Susan and Frank Kavanaugh Robert and Barbara Kleist The…
Read More

MIND Matters, Fall 2017 Newsletter Now Available

By In the News
In this issue of MIND Matters: New grants awarded for cutting-edge science Interview with research participant, Jerry Leth Philanthropist highlight, Steve O'Leary Maria Shriver, celebrity honoree for 8th annual A December to Remember gala Donations to UCI MIND, September 2016 to September 2017 Read more here >
Read More

Bill Gates invests in the fight against Alzheimer’s disease

By In the News
Microsoft co-founder and philanthropist, Bill Gates, blogs on why he has decided to invest in Alzheimer's disease research. He notes, "What I’ve heard from researchers, academics, funders, and industry experts makes me hopeful that we can substantially alter the course of Alzheimer’s if we make progress in five areas: We need to better understand how Alzheimer’s unfolds. We need to detect and diagnose Alzheimer’s earlier. We need more approaches to stopping the disease. We need to make it easier to get people enrolled in clinical trials. We need to use data better." Read more about Gates' commitment to Alzheimer's disease…
Read More

Perspectives on amyloid PET imaging

By Commentary, In the News
A new study published in JAMA Neurology explored participants' perspectives on receiving amyloid PET scan results as part of an Alzheimer’s disease prevention clinical trial, the A4 study.  Participants at UCI MIND contributed to this important research, led by investigators at the University of Pennsylvania (read more about the study here). Amyloid PET is a biomarker test that could someday be used to identify people at increased risk for Alzheimer's disease who may benefit from preventative or disease-delaying treatments. Biomarker testing such as amyloid PET is being used more and more in the research setting to identify participants appropriate for Alzheimer's disease…
Read More

New UCI MIND animal model grant continues to draw attention

By In the News
(from left) Andrea Wasserman, Frank LaFerla, David Baglietto-Vargas, Grant MacGregor, Ali Mortazavi, Kim Green, Andrea Tenner UCI MIND co-director Frank LaFerla and Drs. Andrea Tenner, Kim Green, Grant MacGregor, Marcelo Wood, and David Baglietto-Vargas were awarded an $11.35 million grant from the National Institutes of Health to create the next generation of mouse models to study Alzheimer’s disease. The news released by UCI on October 9 continues to draw local media attention, featured in the LA Times/Daily Pilot and Newport Beach Patch this morning. UCI MIND is already home to the discovery of the first ever mouse model to develop…
Read More

UCI MIND Announces Maria Shriver as Celebrity Honoree for 8th Annual A December to Remember Gala

By Community Events, In the News
Maria Shriver, internationally renowned Alzheimer’s disease advocate, founder of The Women’s Alzheimer’s Movement, and former First Lady of California, will be honored at UCI MIND’s 8th annual A December to Remember gala on Saturday, December 2, 2017. “Maria Shriver is a champion for Alzheimer’s disease research and a voice of strength for many families and individuals who are suffering as a result of this disease,” says Dr. Joshua Grill, co-director of UCI MIND.  “We are proud to partner with Ms. Shriver and honor her important work that continues to shine a light on Alzheimer’s disease.” Shriver is the founder of…
Read More

Research participant highlight – The Groves

By In the News
Marsha and Lionel Grove met in high school and have been married for over 50 years. Marsha graduated from UCLA and worked as a clinical laboratory scientist. Lionel is a USC alumnus and aerospace engineer. They now both participate in multiple studies at UCI MIND. What motivated you to participate in research at UCI MIND? Marsha: Our families are surrounded by Alzheimer’s disease. My sister and my mother both died with Alzheimer’s disease and Lionel has it in his family as well. We’ve experienced it first hand, so we want a cure to be found because we know just how…
Read More

UCI gifted $200 million for Susan and Henry Samueli College of Health Sciences

By In the News
Frank LaFerla, PhD, Co-Director of UCI MIND, Dean of the UCI School of Biological Sciences Today, UCI announced a transformative gift of $200 million to create the Susan and Henry Samueli College of Health Sciences (press release).  The gift is the largest in the history of the university and will launch and will launch a major integrative health initiative that will ultimately benefit all members of the Orange County community and the world. You may be wondering what is integrative medicine?  In the simplest terms, it is an approach that focuses healthcare on the whole person and the whole community, using…
Read More